Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advanced glycation end-products and sclerostin are elevated across diabetes phenotypes and associated with vertebral fractures in type 2 diabetes.

BMC endocrine disorders - 10 Apr 2026

Taskin Kursun Sevdenur, Imre Eren, Gogas Yavuz Dilek

Abstract excerpt

BACKGROUND: To investigate the associations of circulating advanced glycation end-products (AGEs; carboxymethyllysine and pentosidine) and sclerostin with bone mineral density (BMD) and vertebral fractures in adults with type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and latent autoimmune diabetes in adults (LADA). METHODS: In this cross-sectional case–control study, 76 patients with T1DM, 91...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Arginine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Density

Share to Cross-Sectional Studies

Share to Diabetes Mellitus, Type 1

Share to Glycation End Products, Advanced

Share to Lysine

Share to Spinal Fractures

Source

Open in PubMed Open full text

Identifiers

PMID: 41963900
DOI: 10.1186/s12902-026-02254-6
PMCID: PMC13173868

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advanced glycation end-products and sclerostin are elevated across diabetes phenotypes and associated with vertebral fractures in type 2 diabetes.PMID 41963900Read ↗

Complications in the spine associated with type 2 diabetes: The role of advanced glycation end-productsSemantic proximity Read ↗

Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetesSemantic proximity Read ↗

Profiling bone status indices reveals evidence of a low-turnover bone phenotype in type 2 diabetes: findings from the DiaFALL cohort.Semantic proximity Read ↗

Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher Advanced Glycation End-products (AGEs) content and reduced bone strengthSemantic proximity Read ↗

Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus.Semantic proximity Read ↗

Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence.Semantic proximity Read ↗

Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue–Derived Mesenchymal Stem Cells In VitroSemantic proximity Read ↗

The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes.Semantic proximity Read ↗

Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.Semantic proximity Read ↗

Osteoporosis in patients with diabetes mellitus.Semantic proximity Read ↗

Sclerostin as a new target of diabetes-induced osteoporosisSemantic proximity Read ↗

Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in KuwaitSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.